68Ga-PSMA-11 not checked
Telix Pharmaceuticals (Innovations) Pty Limited · gallium Ga 68 Gozetotide
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “The radioconjugate 68Ga-PSMA-11 is composed of a human PSMA-targeting ligand peptide conjugated via the acyclic radiometal chelator, N, N'-bis \[2-hydroxy-5-(carboxyethyl)benzyl\] ethylenediamine-N, N'-diacetic acid (HBED-CC) to the radioisotope Gallium68 ( 68Ga); which binds to PSMA on the surface of cells expressing PSMA, including malignant prostate cancer cells, which usually overexpress…”In the company’s words, NCT07052214 on ClinicalTrials.gov
- Tested for
- PCA, Prostate Cancer, Prostatic Neoplasm, PSMA PET, Diagnostic Imaging, Elevated PSA, Positron Emission Tomography, Prostate Biopsy and 1 more
- Main trialPhase 3
- “This is an open label, longitudinal Phase 3 study of prostate specific membrane antigen (PSMA) positron emission tomography (PET) combined with magnetic resonance imaging (MRI) compared to standard of care (SOC) for the detection of prostate cancer (PCa).”In the company’s words, NCT07052214 on ClinicalTrials.gov
- Other names
- Illucix · gallium Ga 68 Gozetotide · Illuccix
Other drugs for Prostate Cancer
- ApalutamideJanssen Research & Development, LLC · Phase 3
- 64Cu-SAR-bisPSMAClarity Pharmaceuticals Ltd · Phase 3
- Abiraterone acetateJanssen Research & Development, LLC · Phase 3
- EnzalutamidePfizer · Astellas · Phase 3
- MevrometostatPfizer · Phase 3
- Aglatimagene besadenovecCandel Therapeutics · Phase 3
Coming up1
- Jan 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | Jan 2027 | PSMA PET Combined With MRI for the Detection of PCa | |
| Phase 3Unknown | 30 Dec 2025 | 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026